Megan Dalton, PA
Medical · Marietta, GANPI 1013567452
Payments from drug & device makers
Across 167 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$448
- Daiichi Sankyo Inc.$436
- AbbVie$258
- AstraZeneca$230
- Novartis$223
- Regeneron Healthcare Solutions, Inc.$169
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,38795%
- Education$1935%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 16 | $448 |
| Daiichi Sankyo Inc. | 22 | $436 |
| AbbVie | 11 | $258 |
| AstraZeneca(2 entities) | 11 | $230 |
| Novartis | 11 | $223 |
| Regeneron Healthcare Solutions, Inc. | 6 | $169 |
| Pfizer | 7 | $147 |
| Sobi, Inc | 6 | $130 |
| Beone Medicines USA, Inc. | 6 | $116 |
| Incyte Corporation | 6 | $114 |
| GSK | 5 | $104 |
| Bristol Myers Squibb | 4 | $101 |
| Sanofi | 4 | $97 |
| Merck | 3 | $75 |
| Seagen Inc. | 4 | $74 |
| E.r. Squibb & Sons, L.L.C. | 4 | $74 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $73 |
| Karyopharm Therapeutics Inc. | 4 | $67 |
| Gilead(2 entities) | 3 | $58 |
| Array Biopharma Inc | 4 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Jazz Pharmaceuticals Inc. | 2 | $47 |
| Bayer | 2 | $45 |
| Pharmaessentia USA Corporation | 2 | $44 |
| Agios Pharmaceuticals, Inc. | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Coherus Oncology, Inc. | 2 | $37 |
| Lilly USA, LLC | 1 | $25 |
| Recordati_rare_diseases_inc. | 1 | $21 |
| Blueprint Medicines Corporation | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Syndax Pharmaceuticals, Inc. | 1 | $18 |
| EMD Serono, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Eisai Inc. | 1 | $15 |
| Dendreon Pharmaceuticals LLC | 1 | $15 |
| Geron Corporation | 1 | $15 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Exelixis Inc. | 1 | $14 |
How this compares
$3,580 in reported general payments places this provider in the 75th percentile of 950 medical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| KisqaliRibociclib Succinate | 13 | $182,932 |
| EliquisApixaban | 34 | $21,724 |
| XareltoRivaroxaban | 11 | $10,512 |
| Exemestane | 40 | $4,183 |
| Letrozole | 110 | $2,745 |
| Anagrelide Hcl | 17 | $1,168 |
| Tamoxifen Citrate | 57 | $1,042 |
| Anastrozole | 47 | $827 |
| Sucralfate | 13 | $824 |
| ValacyclovirValacyclovir Hcl | 24 | $374 |
| Prochlorperazine Maleate | 25 | $301 |
| Ondansetron Hcl | 30 | $230 |
| Pantoprazole Sodium | 35 | $222 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 17 | $218 |
| Pregabalin | 11 | $153 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisKisqali | $223 | $182,93213 claims |
| PfizerEliquis | $147 | $21,72434 claims |
| Johnson & JohnsonXarelto | $448 | $10,51211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 950 medical providers in Georgia.
Other medical in Marietta
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Jewel SawyerMarietta$74K
- Sarah MillerMarietta$10K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Felicia HoffmanRoswell$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.